Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
2
×
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
akcea therapeutics
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
barry greene
biomarin pharmaceutical
biotech
bluebird bio
boston
boston university
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
competitive generic therapy
cystic fibrosis
dan ollendorf
deals
detroit blog main
detroit top stories
drugs
gene therapy
What
fda
2
×
patients
2
×
ago
alnylam
approve
aren’t
awaits
bio
biological
crossed
decades
decision
developers
discovered
drug
drugs
fingers
friday
gene
help
historic
imminent
long
medicare
medicine
moves
news
noteworthy
prices
rna
road
roundup
rulings
separate
therapy
they’ll
time
trick
uses
winding
Language
Current search:
fda
×
patients
×
" alnylam pharmaceuticals "
×
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
